丽珠医药(01513):JP-1366片获得药物临床试验批准通知书

智通财经
Apr 10

智通财经APP讯,丽珠医药(01513)发布公告,近日,丽珠医药集团股份有限公司 Livzon Pharmaceutical Group Inc.*收到国家药品监督管理局核准签发的《药物临床试验批准通知书》(通知书编号:2026LP01115),同意公司申报的申报的 JP-1366 片开展“与适当的抗生素联用以根除幽门螺杆菌”适应症的临床试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10